DXCM R&D Expenses

Dexcom · R&D Expenses

DXCM logo

DXCM R&D Expenses

Latest reported$604.00M
DXCM R&D Expenses ($2.90M → $604.00M)
High-resolution chart · PNG

DXCM r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
599,100,000
552,400,000
505,800,000
484,200,000
604,200,000
359,900,000
273,500,000
417,400,000
185,400,000
156,100,000
137,500,000
69,400,000
44,800,000
39,500,000
30,747,000
23,227,000
14,294,000
19,629,000
16,131,000
19,419,550
26,769,514
12,469,842
8,934,631
6,310,907
5,039,000
2,902,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.